Using nanotechnology, a team of researchers at Washington University in St. Louis has eliminated the need for refrigeration for biomarkers used in medical diagnostic testing. The researchers recently gave their new tech a real-world test by sending it through the mail.
Engineers at Washington University in St. Louis are using nanoparticle technology in an effort to meet the ever-increasing demand for food. Their innovative technique boosts the growth of a protein-rich bean by improving the way it absorbs nutrients, while reducing the need for fertilizer.
Engineers at Washington University in St. Louis use nanoparticle technology, applied to a drug found in most people’s medicine cabinets, to chemically alter a cancer tumor and stop its growth.
Researchers at Washington University in St. Louis, led by Srikanth Singamaneni, PhD, associate professor of materials science in the School of Engineering & Applied Science, are using color-shifting nanoparticles of gold, combined with specifically engineered artificial antibodies, to detect biochemical signs of kidney damage.
Researchers led by Samuel Achilefu, PhD, at the School of Medicine have devised a way to apply light-based therapy to deep tissues never before accessible. Instead of shining an outside light, they delivered light directly to tumor cells, along with a photosensitive source of free radicals that can be activated by the light to destroy cancer.
The Food and Drug Administration (FDA) has approved for testing in people a nanoparticle-based imaging agent jointly developed at the School of Medicine and collaborating institutions. The imaging agent may illuminate dangerous plaque in arteries, and doctors hope to use it to identify patients at high risk of stroke.
A research team including Elijah Thimsen, PhD, assistant professor of energy, environmental & chemical engineering in the School of Engineering & Applied Science, has developed a technique to increase the performance and electrical conductivity of thin films used to print solar cells from inks.
Samuel A. Wickline, MD, has been chosen to receive the Chancellor’s Award for Innovation and Entrepreneurship at Washington University in St. Louis. He will receive the honor Saturday, Dec. 6. Faculty achievement awards will be presented to David A. Balota, PhD, and Steven L. Teitelbaum, MD.
Samuel A. Wickline, MD, has been named the inaugural James R. Hornsby Family Professor of Biomedical Sciences at Washington University School of Medicine.
Two executives of a publicly traded venture capital firm that invests in nanotechnology companies will discuss “The Changing Face of Venture Capital and the Potential Impact to St. Louis” at 4:30 p.m. Thursday, Oct. 18, in the Preston M. Green Hall Collaboration Space.